WHO对于SARS和用血安全的建议

• 作 者: 飞燕
• 出 处: 中华医学信息导报
• 发表日期: 2003年10期
• 关键词: 用血安全 WHO 血液安全 血制品 病人症状 血液制品 临床技术 受血者 天后 细胞移植

虽然SARS病例的传播不可能归咎于不安全的血制品或血液衍化物,但是理论上存在SARS病毒可以通过血制品传播的风险。因为疑似SARS病人症状发作大约10天后,血液中可检测到低含量的病毒(参照严重急性呼吸综合征病人的冠状病毒的鉴定)。 世界卫生组织的血液安全和临床技术部门就

Although the spread of SARS cases can not be attributed to unsafe blood products or blood derivatives, there is a theoretical risk that the SARS virus can spread through blood products. Because about 10 days after the onset of symptoms of a suspected SARS patient, low levels of the virus can be detected in the blood (refer to the identification of coronavirus in SARS patients). The WHO Department of Blood Safety and Clinical Technology has just completed